Science
Jemincare group has completed the Phase I clinical trial of its anti-SARS-CoV-2 neutralizing antibody JMB2002 – The Korea Herald
SHANGHAI, Sept. 14, 2021 /PRNewswire/ — Recently, Jemincare group has declared that it has completed phase I clinical trial…
SHANGHAI, Sept. 14, 2021 /PRNewswire/ — Recently, Jemincare group has declared that it has completed phase I clinical trial of self-developed novel coronavirus specific neutralizing antibody (Project code: JMB2002).
The clinical trial of JMB2002 was stated…
Continue Reading
-
General24 hours agoFrom jackaroo to ‘Golden Tonsils’ radio titan: the life and career of John Laws
-
General15 hours agoAFL gives teams finishing 10th chance to win premiership through wildcard round in finals
-
General11 hours agoPrincess Anne remembers Porepunkah police officers in wreath-laying ceremony in Melbourne
-
Noosa News11 hours agoDingo hunts shark in shallow waters off K’gari, Queensland